{
  "id": 3653183,
  "title": "Mpm Bioventures 2018 sells $461,545 of Entrada Therapeutics stock",
  "url": "https://urgent.news/2026/08/27/mpm-bioventures-2018-sells-461-545-of-entrada-therapeutics-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-27T03:16:31.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/mpm-bioventures-2018-sells-461545-of-entrada-therapeutics-stock-93CH-4878296"
  },
  "original_language": "en",
  "account": "MPM BioVentures 2018, a 10% shareholder and director of Entrada Therapeutics, sold 62,714 shares of the company's common stock totaling $461,545. The transactions took place over three days in August 2026, with prices fluctuating between $7.06 and $7.54 per share. The stock experienced a decline of about 8% over the week, trading at $7 against a market capitalization of $252 million. InvestingPro analysis suggests the stock is undervalued, with a Fair Value of $7.95. The fund disposed of 21,623 shares on August 24 at an average price of $7.34, 26,522 shares on August 25 at $7.54, and 14,569 shares on August 26 at $7.06. After these sales, MPM BioVentures 2018, L.P. and its affiliated entities now own 4,318,348 shares of Entrada Therapeutics. The company's management is facing financial challenges, with analysts maintaining price targets between $11 and $25 per share. Despite this, the investment fund continues to hold a significant stake in the company.",
  "summary": null,
  "key_points": [
    "MPM BioVentures 2018 sold 62,714 shares of Entrada Therapeutics for $461,545 in August 2026.",
    "Stock prices fluctuated between $7.06 and $7.54 per share during the sales.",
    "After the sales, MPM BioVentures 2018 retains 4,318,348 shares in the company."
  ],
  "editors_take": "MPM BioVentures 2018's sale of Entrada Therapeutics stock reduces its stake but maintains a significant position, amid analyst expectations and an InvestingPro assessment that the stock is undervalued.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Mpm Bioventures sells $461,545 in Entrada Therapeutics stock",
        "url": "https://urgent.news/2026/08/27/mpm-bioventures-sells-461-545-in-entrada-therapeutics-stock",
        "published": "2026-08-27T03:16:30.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}